Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × edoxaban × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 5 Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1 Myeloproliferative Disorders 1 Embolism 1

Interventions

Surveys and Questionnaires 71 Blood Specimen Collection 45 Interviews as Topic 24 Data Collection 15 Radiotherapy 12 Observation 11 Magnetic Resonance Spectroscopy 11 Exercise 11 Watchful Waiting 9 Hematologic Tests 9 Drug Therapy 9 Quality of Life 8 Therapeutics 6 Specimen Handling 6 Focus Groups 6 Biopsy 6 Phlebotomy 5 Magnetic Resonance Imaging 5 Lapatinib 5 pembrolizumab 4 Trastuzumab 4 Standard of Care 4 Restraint, Physical 4 Palliative Care 4 Nivolumab 4 Neoadjuvant Therapy 4 Mental Status and Dementia Tests 4 Ipilimumab 4 High-Throughput Nucleotide Sequencing 4 Base Sequence 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04618913 2026-03-12

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡